Insight 22.01.20222021 has been a fast-moving year with unprecedented milestones for Nice & Green. Find out more in our “Year In Review”.Read more
Funding 27.12.2021Nice & Green extends its support to the Swiss biotech Evolva with additional financing of CHF 12MRead more
Funding 23.12.2021Nice & Green provides Endurance Motive with EUR 2.4 million in funding to support its development and growth projectsRead more
Insight 09.11.2021Nice & Green participates in the IPO of the French biotech MaaT Pharma now listed on Euronext ParisRead more
Funding 04.11.2021Nice & Green enters a 4-year investment partnership with EEMS Italia SpA which will consolidate its presence in the Energy Transition market by 2026Read more
